A landmark year for Poolbeg Pharma #POLB – Alan Green talks to CEO Jeremy Skillington, who takes us through what has been a very eventful year since the IPO. At 01:58 we discuss the flagship asset POLB 001, which reached a major milestone last week as it commenced a human challenge trial. At 05:00 Jeremy provides an overview of two collaborations in Artificial Intelligence and how Poolbeg will use these pioneering approaches to identify new treatments for infectious diseases. At 08:57 Jeremy outlines what investors should expect for the remainder of 2022.
Power Metal Resources #POW CEO Paul Johnson talks to Alan Green and updates on the latest developments, the ramifications of the Ukraine invasion, the upcoming AGM on March 30th and a further GM to seek shareholder approval to consider shareholder distributions. We also discuss the upcoming IPO’s and milestones, and what shareholders can expect in the near term.
February 2022 – Alan Green talks to Power Metal Resources #POW CEO Paul Johnson. We discuss the challenges faced by small cap listed resource companies in navigating their way through quiet markets, and how investors deal with the conditions. Paul then covers progress with the upcoming spin out IPO’s, and we look at what shareholders can expect from Power Metal in the first half of 2022.
In the third of a four part interview, Alan Green talks to Power Metal Resources #POW CEO Paul Johnson. Today we cover Financing, and in the final part tomorrow we’ll look at Group Strategy.
In the second of a four part interview, Alan Green talks to Power Metal Resources #POW CEO Paul Johnson. Today we cover Exploration, and in the coming days we’ll look at the Financing Model and Group Strategy.
In the first of a four part interview, Alan Green talks to Power Metal Resources #POW CEO Paul Johnson. Today we cover Project Spin Outs, and in the coming days we’ll look at Exploration, Financing Model and Group Strategy.
Power Metal Resources #POW – Alan Green and Paul Johnson discuss the latest developments during November, including the FDR Australia acquisition and Selta uranium project addition, Alamo gold project developments, Kavango Resources’ stake in Kalahari Key Minerals and Molopo Farms and the upcoming Golden Metal Resources IPO. Paul also gives his view on the share price and the malaise in junior mining stocks.
Poolbeg Pharma #POLB Exec Chairman Cathal Friel and CEO Jeremy Skillington talk to Alan Green about the company’s ‘capital light’ business model. We discuss the POLB 001 asset, spun out of Open Orphan #ORPH, data samples, the PredictViral and vaccine discovery platforms plus further pipeline products. Cathal discusses the company cash position, and Jeremy highlights the upcoming value inflection points for investors and shareholders.
I would like to receive Brand Communications updates and news...
